Gene therapy for urologic cancer
- PMID: 12084223
- DOI: 10.1007/s11934-002-0014-7
Gene therapy for urologic cancer
Abstract
Advances in molecular technology and the completion of the human genome project have ushered in a new era of medicine, that of gene therapy. In every field of medicine, investigators are developing gene therapeutics in an attempt to cure diseases. Urologic oncology is no exception. Herein, we review the current status of gene therapy for urologic malignancy. Included is an overview of advances in gene delivery systems and immunology, which are driving forces for gene therapy research. Finally, we review the current gene therapy trials and experimental approaches for urologic malignancy.
Similar articles
-
Immune gene therapy in urology.Curr Urol Rep. 2002 Feb;3(1):82-9. doi: 10.1007/s11934-002-0015-6. Curr Urol Rep. 2002. PMID: 12084224 Review.
-
Potential role for metformin in urologic oncology.Investig Clin Urol. 2016 May;57(3):157-64. doi: 10.4111/icu.2016.57.3.157. Epub 2016 May 10. Investig Clin Urol. 2016. PMID: 27195314 Free PMC article. Review.
-
Gene therapy--the future is here: a guide to the practicing urologist.Urology. 1998 Mar;51(3):367-80. doi: 10.1016/s0090-4295(97)00624-9. Urology. 1998. PMID: 9510338 Review. No abstract available.
-
The role of imaging in the surveillance of urologic malignancies.Urol Clin North Am. 2006 Aug;33(3):377-96. doi: 10.1016/j.ucl.2006.03.001. Urol Clin North Am. 2006. PMID: 16829272 Review.
-
Gene therapy in urological oncology: principles, strategies and potential.Eur Urol. 1994;25(3):177-82. doi: 10.1159/000475279. Eur Urol. 1994. PMID: 8200398 Review. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Medical